Email ID
Password
Scrip   
US probes Shire's marketing of ADHD drugs
06 November 2009
Nancy Faigen

Shire Pharmaceuticals has received a subpoena from US investigators related to the marketing of its three attention deficit/hyperactivity disorder (ADHD) treatments, the company recently disclosed in its third quarter earnings announcement.

The September 23rd subpoena came from the office...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36